- Home
- AXSM vs NXE Comparison
AXSM vs NXE Comparison
Compare AXSM & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXSM | NXE |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 6.2B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AXSM | NXE |
|---|---|---|
| Price | $184.97 | $11.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 21 | 0 |
| Target Price | ★ $189.57 | N/A |
| AVG Volume (30 Days) | 806.9K | ★ 7.2M |
| Earning Date | 02-17-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $561,263,000.00 | N/A |
| Revenue This Year | $67.10 | N/A |
| Revenue Next Year | $58.73 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 65.83 | N/A |
| 52 Week Low | $86.99 | $3.91 |
| 52 Week High | $184.40 | $12.19 |
Technical Indicators
Market Signals| Indicator | AXSM | NXE |
|---|---|---|
| Relative Strength Index (RSI) | 64.78 | 77.40 |
| Support Level | $172.05 | $11.06 |
| Resistance Level | $179.00 | $11.33 |
| Average True Range (ATR) | 7.51 | 0.49 |
| MACD | 0.33 | 0.15 |
| Stochastic Oscillator | 81.87 | 88.66 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About NXE Nexgen Energy Ltd.
NexGen Energy Ltd is an exploration and development entity engaged in acquiring, evaluating, and developing uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin.